ReZolve Bioresorbable Sirolimus-Eluting Coronary Scaffold: Completed pilot trial enrollment

Reva completed enrollment of 26 patients with symptomatic coronary artery disease due to one or more discrete areas of blockage in the open-label, international RESTORE pilot trial evaluating ReZolve ...